We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QEP
576
DELISTED
QEP RESOURCES, INC.
QEP
| $6.79M | 0.02% |
5,263,264
-4,652,915
| -47% | -$4.34M |
|
|
LOGC
577
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $6.77M | 0.02% |
800,000
-115,355
| -13% | -$759K |
|
578
Equitable Holdings
EQH
$13.2B
| $6.75M | 0.02% |
350,000
+150,000
| +75% | +$2.68M |
|
579
Velocity Financial
VEL
$700M
| $6.71M | 0.02% |
1,700,000
+160,102
| +10% | +$602K |
|
580
Newell Brands
NWL
$2.61B
| $6.7M | 0.02% |
421,600
-7,700
| -2% | -$106K |
|
581
Columbus McKinnon
CMCO
$622M
| $6.69M | 0.02% |
+200,000
| New | +$5.52M |
|
582
Robert Half
RHI
$4.19B
| $6.68M | 0.02% |
126,400
-2,200
| -2% | -$104K |
|
|
HOUS
583
DELISTED
Anywhere Real Estate
HOUS
| $6.67M | 0.02% |
+900,000
| New | +$4.64M |
|
584
Federal Realty Investment Trust
FRT
$10.6B
| $6.64M | 0.02% |
77,900
-1,400
| -2% | -$113K |
|
585
Zions Bancorporation
ZION
$10.5B
| $6.51M | 0.02% |
191,486
-9,500
| -5% | -$301K |
|
586
Aurinia Pharmaceuticals
AUPH
$1.92B
| $6.5M | 0.02% |
400,000
| – | – |
|
587
Kimco Realty
KIM
$16.9B
| $6.42M | 0.02% |
500,063
+42,000
| +9% | +$467K |
|
|
FARM
588
DELISTED
Farmer Brothers
FARM
| $6.38M | 0.02% |
869,699
| – | – |
|
|
SCS
589
DELISTED
Steelcase
SCS
| $6.33M | 0.02% |
524,517
-873,320
| -62% | -$9.55M |
|
590
EPAM Systems
EPAM
$5.85B
| $6.3M | 0.02% |
25,000
| – | – |
|
591
Arcus Biosciences
RCUS
$3.62B
| $6.18M | 0.02% |
+250,000
| New | +$6.75M |
|
|
MNRL
592
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $6.17M | 0.02% |
500,000
+167,528
| +50% | +$2.03M |
|
593
American Airlines Group
AAL
$11B
| $6.17M | 0.02% |
472,322
+73,965
| +19% | +$897K |
|
|
NLSN
594
DELISTED
Nielsen Holdings plc
NLSN
| $6.12M | 0.02% |
411,803
+6,809
| +2% | +$95.4K |
|
|
AIV
595
Aimco
AIV
$384M
| $6.09M | 0.02% |
1,214,218
+931,594
| +330% | +$4.62M |
|
596
LPL Financial
LPLA
$27.9B
| $6.05M | 0.02% |
77,161
+27,161
| +54% | +$1.81M |
|
597
Perrigo
PRGO
$1.49B
| $5.97M | 0.02% |
107,996
-2,800
| -3% | -$148K |
|
598
SL Green Realty
SLG
$3.97B
| $5.96M | 0.02% |
124,995
+24,483
| +24% | +$1.12M |
|
599
MeiraGTx Holdings
MGTX
$1.14B
| $5.95M | 0.02% |
475,000
| – | – |
|
600
HBT Financial
HBT
$1.31B
| $5.89M | 0.02% |
441,883
| – | – |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.